Tabulating Group Sequential Designs for Clinical Trials: Lucid, Structured, and Compact Summaries
Authors: Yujie Zhao (Merck & Co., Inc., Rahway, NJ, USA), Hiroaki Fukuda (MSD K.K., Japan), John Blischak (Merck & Co., Inc., Rahway, NJ, USA, working under contract with AgileOne, Torrance, CA, USA), and Keaven Anderson (Merck & Co., Inc., Rahway, NJ, USA)
yujie-website
john-website
keaven-website
Full Description:
When it comes to clinical trials involving time-to-event endpoints, designing studies to determine the necessary sample size for a desired power is a common practice. The package gsDesign2 provides a tool that efficiently consolidates and organizes extensive design information into a single, concise, and coherent table.
Table Type: static-HTML
Submission Type: Tutorial
Table: RPubs - Document
Code: GitHub - Merck/gsDesign2: Group Sequential Design Under Non-Proportional Hazards
Language:
Industries: Pharmaceutical industry.
Packages: gt